These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34907794)

  • 21. Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US.
    Rodriguez EVC; Bouazza FZ; Dauby N; Mullier F; d'Otreppe S; Jissendi Tchofo P; Bartiaux M; Sirjacques C; Roman A; Hermans C; Cliquennois M
    Infection; 2022 Apr; 50(2):531-536. PubMed ID: 34626338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral venous sinus thrombosis after ChAdOx1 vaccination: the first case of definite thrombosis with thrombocytopenia syndrome from India.
    Maramattom BV; Moidu FM; Varikkottil S; Syed AA
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34706921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-benefit analysis for people < 60 years in Australia.
    MacIntyre CR; Veness B; Berger D; Hamad N; Bari N
    Vaccine; 2021 Aug; 39(34):4784-4787. PubMed ID: 34272095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis.
    Kim AY; Woo W; Yon DK; Lee SW; Yang JW; Kim JH; Park S; Koyanagi A; Kim MS; Lee S; Shin JI; Smith L
    Int J Infect Dis; 2022 Jun; 119():130-139. PubMed ID: 35339716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination.
    van de Munckhof A; Krzywicka K; Aguiar de Sousa D; Sánchez van Kammen M; Heldner MR; Jood K; Lindgren E; Tatlisumak T; Putaala J; Kremer Hovinga JA; Middeldorp S; Levi M; Arnold M; Ferro JM; Coutinho JM
    Eur J Neurol; 2022 Jan; 29(1):339-344. PubMed ID: 34536256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ischemic Stroke and Vaccine-Induced Immune Thrombotic Thrombocytopenia following COVID-19 Vaccine: A Case Report with Systematic Review of the Literature.
    Cascio Rizzo A; Giussani G; Agostoni EC
    Cerebrovasc Dis; 2022; 51(6):722-734. PubMed ID: 35512656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.
    Sánchez van Kammen M; Heldner MR; Brodard J; Scutelnic A; Silvis S; Schroeder V; Kremer Hovinga JA; Middeldorp S; Levi M; Hiltunen S; Lindgren E; Mansour M; Arauz A; Barboza MA; Zuurbier SM; Aguiar de Sousa D; Ferro JM; Fischer U; Field TS; Jood K; Tatlisumak T; Putaala J; Arnold M; Coutinho JM
    JAMA; 2021 Jul; 326(4):332-338. PubMed ID: 34213527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early Outcomes of Bivalirudin Therapy for Thrombotic Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S Vaccination.
    Clark RT; Johnson L; Billotti J; Foulds G; Ketels T; Heard K; Calvello Hynes E
    Ann Emerg Med; 2021 Oct; 78(4):511-514. PubMed ID: 34226070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies.
    Kanack AJ; Singh B; George G; Gundabolu K; Koepsell SA; Abou-Ismail MY; Moser KA; Smock KJ; Green D; Major A; Chan CW; Wool GD; Reding M; Ashrani AA; Bayas A; Grill DE; Padmanabhan A
    Am J Hematol; 2022 May; 97(5):519-526. PubMed ID: 35132672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of coagulation and proinflammatory pathways in thrombosis with thrombocytopenia syndrome and following COVID-19 vaccination.
    Aid M; Stephenson KE; Collier AY; Nkolola JP; Michael JV; McKenzie SE; Barouch DH
    Nat Commun; 2023 Oct; 14(1):6703. PubMed ID: 37872311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple Electrode Aggregometry (Multiplate): Functional Assay for Vaccine-Induced (Immune) Thrombotic Thrombocytopenia (VITT).
    Kong Y; Kershaw G; Fu YKS; Passam F
    Methods Mol Biol; 2023; 2663():429-440. PubMed ID: 37204728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine-induced immune thrombotic thrombocytopenia post dose 2 ChAdOx1 nCoV19 vaccination: Less severe but remains a problem.
    Clarke L; Brighton T; Chunilal SD; Lee CSM; Passam F; Curnow J; Chen VM; Tran HA
    Vaccine; 2023 May; 41(20):3285-3291. PubMed ID: 37085453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral venous sinus thrombosis in the setting of COVID-19 vaccination: a systematic review and meta-analysis.
    Palaiodimou L; Stefanou MI; de Sousa DA; Coutinho JM; Papadopoulou M; Papaevangelou V; Vassilakopoulos TI; Tsiodras S; Filippou DK; Tsivgoulis G
    J Neurol; 2022 Jul; 269(7):3413-3419. PubMed ID: 35394172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Possible vaccine-induced immune thrombotic thrombocytopenia in a patient with diabetes and chronic kidney disease or random association?].
    Comolli S; Del Vecchio L; De Micheli V; Tucci B; D'Amico M; Fumagalli G; Gallelli B; Gervasi F; Mezzina N; Tettamanti M; Melfa G
    G Ital Nefrol; 2022 Dec; 39(6):. PubMed ID: 36655834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccine-induced immune thrombotic thrombocytopenia in a male after Ad26.COV2.S vaccination presenting as cerebral venous sinus thrombosis.
    Wu JF; Bajwa U; Hammad M
    Platelets; 2022 Jul; 33(5):797-800. PubMed ID: 35535430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kidney Transplantation from a Deceased Donor with COVID-19 Ad26.COV2-S Vaccine-Induced Thrombotic Thrombocytopenia.
    Neretljak I; Jurenec F; Smojver H; Jurekovic Z
    Am J Case Rep; 2023 Apr; 24():e938730. PubMed ID: 37087559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US.
    Li X; Burn E; Duarte-Salles T; Yin C; Reich C; Delmestri A; Verhamme K; Rijnbeek P; Suchard MA; Li K; Mosseveld M; John LH; Mayer MA; Ramirez-Anguita JM; Cohet C; Strauss V; Prieto-Alhambra D
    BMJ; 2022 Oct; 379():e071594. PubMed ID: 36288813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Update on COVID-19 Vaccine Induced Thrombotic Thrombocytopenia Syndrome and Some Management Recommendations.
    Islam A; Bashir MS; Joyce K; Rashid H; Laher I; Elshazly S
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of ChAdOx1 nCoV-19 and Ad26.COV2.S SARS-CoV-2 vector vaccines.
    Michalik S; Siegerist F; Palankar R; Franzke K; Schindler M; Reder A; Seifert U; Cammann C; Wesche J; Steil L; Hentschker C; Gesell-Salazar M; Reisinger E; Beer M; Endlich N; Greinacher A; Völker U
    Haematologica; 2022 Apr; 107(4):947-957. PubMed ID: 35045692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Outcomes after Vaccine-Induced Thrombotic Thrombocytopenia.
    Panagiota V; Dobbelstein C; Werwitzke S; Ganser A; Cooper N; Sachs UJ; Tiede A
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.